YourVoice.Now Summary
Transparency & AccountabilityThe U.S. would review the global anti-doping agency each year — and could hold back dues if it falls short.
Transparency & Accountability
Each year, the White House drug policy office would judge whether the agency is run fairly and gives athletes a real say. It would ask U.S. anti-doping and Olympic officials, plus an athletes' council, before it decides.
A failing review would let the office keep back up to all of the U.S. membership dues, after consulting congressional committees. The office would also have to use its best efforts to bring the agency into line.
If the review fails, the office would write to four committees in Congress. The report would spell out what blocks a fair U.S. role at the agency.
Before sending any money to the agency, the office would have to tell Congress how it plans to spend it. This applies to every payment, not just years when the review fails.
Dues held back but not committed by the end of the budget year would return to the U.S. Treasury's general fund. The office could not carry that money over or spend it elsewhere, unless another law says so.
More about this bill
Most people would notice no change in daily life. The bill deals with how the United States treats the World Anti-Doping Agency. That agency writes the drug-testing rules used at the Olympics. U.S. Olympic and Paralympic athletes are the group closest to any effect. Within 180 days, the White House drug policy office (ONDCP) would have to judge whether the agency is run fairly. It would ask whether the agency is independent and has made its promised reforms. It would also ask whether athletes get a real say. That check would repeat every year. If the agency falls short, the office could hold back some or all U.S. dues. The office would also have to tell Congress what is blocking a fair U.S. role. Money held back but not spent by year's end would go back to the Treasury. And 30 days before paying the agency, the office would have to send Congress a spending plan.
Congressional Summary
Restoring Confidence in the World Anti-Doping Agency Act of 2025 This bill requires the Office of National Drug Control Policy (ONDCP) to annually evaluate the governance and procedures of the World Anti-Doping Agency (WADA). Specifically, the ONDCP, in consultation with the United States Anti-Doping Agency, the United States Olympic and Paralympic Committee, the Athletes' Advisory Council (Team USA AC), must determine whether WADA has a credible and independent governance model that provides for fair representation of the United States; fully implements or has implemented governance reforms to ensure independent governance; and has fair processes and procedures for selecting independent athletes for decision-making roles on the WADA Executive Committee, the WADA Foundation Board, and relevant expert advisory groups, standing committees, permanent special committees, and working groups of WADA. If the ONDCP determines WADA has not met these criteria, the ONDCP must use all available tools and efforts to bring WADA into compliance with them. Further, upon such a determination, the ONDCP may withhold up to the full amount of the United States' membership dues to WADA.
Legislative Subjects
Details
- Congress
- 119th
- Chamber
- Senate
- Status
- summarized
- Action
- Reported to Senate
- Action Date
- 2026-02-23
- Date Added
- 2026-06-29
- Source
- Congress.gov →
Like reading a bill in plain English?
We're building an app that does this for every bill in Congress and lets you tell your reps how you want them to vote. We're a small team getting ready to launch, and we're trying to show investors that real people want this. Be one of them. Help us get it built. Leave your email and we'll tell you the moment the app is ready.